Bio-Thera Launches Adalimumab In China

Qletli Biosimilar Is First Chinese Humira Rival

 
• By David Wallace
  
First
Qletli is Bio-Thera’s First Launch, The Firm's First Approved Biosimilar And The First Chinese Rival To Humira • Source: Shutterstock

More from Products

More from Generics Bulletin